Loading organizations...
§ Private Profile · Shenzhen, Guangdong, China
high-tech firm applying human micro-ecological technology to create solutions for health, clinical research, and disease.
01 Life Science and Technology is a biotechnology firm that applies human micro-ecological technology to develop solutions for clinical research, disease diagnosis, and general health management. The organization operates a proprietary human micro-ecological technology platform designed to support the creation of novel therapeutics and wellness products. Within its development pipeline, the company is advancing HL-201, a preclinical treatment candidate specifically targeted at addressing acne vulgaris. The firm provides its technological applications and research capabilities to both individual consumers seeking health interventions and institutional organizations conducting clinical trials. Operating in the broader life sciences sector, the enterprise focuses on translating microbiome research into commercial medical applications and diagnostic tools. The company maintains its primary focus on advancing its preclinical assets through the regulatory pipeline while expanding its broader micro-ecological research initiatives.
01 Life Science and Technology has raised $14.5M across 1 funding round.
01 Life Science and Technology has raised $14.5M in total across 1 funding round.
01 Life Science and Technology has raised $14.5M in total across 1 funding round.
01 Life Science and Technology's investors include Cloud Capital, Green Future, Songhe Capital.
01 Life Science and Technology has raised $14.5M across 1 funding round. Most recently, it raised $14.5M Series B in April 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 21, 2023 | $14.5M Series B | — | Cloud Capital, Green Future, Songhe Capital | Announced |